Entity

Time filter

Source Type


Yang J.,Vanderbilt University | Feng F.,Jiangsu Key Laboratory of Carcinogenesis and Intervention | Guo Q.-L.,Jiangsu Key Laboratory of Carcinogenesis and Intervention | Guo Q.-L.,State Key Laboratory of Natural Medicines | And 3 more authors.
Zhongguo Zhongyao Zazhi | Year: 2013

Gamboge, the resin of Garcinia hanburyi has had a long history of use as the traditional dye as well as a complementary and alternative medicine. The antitumor activities of gamboge have been well demonstrated by inhibiting the growth and progression of cancer cells both in vitro and in vivo. In order to further clarify the mode of action of gamboge, there are three key questions needed to be answered, including what's in gamboge? How do the chemical components from gamboge work on cancer cells? How do biological systems work on the chemical components from gamboge after administration? In this review, we summarize the explorations of the answers toward these questions according to the recent progress in both of chemistry and biology research of gamboge. In addition, the implication in the future research and discovery of the caged G. xanthones as anticancer agents is also discussed. Source


Jiang C.,Jiangsu Key Laboratory of Carcinogenesis and Intervention | Jiang C.,China Pharmaceutical University | Zhang X.,Jiangsu Key Laboratory of Carcinogenesis and Intervention | Zhang X.,China Pharmaceutical University | And 4 more authors.
Progress in Chemistry | Year: 2010

Inhibition of kinesin spindle protein (KSP) represents a novel and specific mechanism to target the mitotic spindle that may be devoid of the neuropathy-associated side effects common to the agents that target microtubules. Since the discovery of monastrol, the first selective small molecular inhibitor of KSP, many types of KSP inhibitors have been reported. In this review we describe the development of different types of KSP inhibitors. The structures and functions of KSP and the use of which as a novel target in the research of anticancer agents are introduced. The structure-activity relationship of some KSP inhibitors and the perspective of the study on KSP inhibitors are also discussed. Source

Discover hidden collaborations